T I-relaxation time changes over five years in relapsing-remitting multiple sclerosis

Multiple Sclerosis

Volumn 16, Issue 4, 2010, Pages 427-433

  Papadopoulos, Konstantinos ^a   Tozer, Daniel J ^b   Fisniku, Leonora ^b   Altmann, Daniel R ^b,c   Davies, Gerard ^b   Rashid, Waqar ^b   Thompson, Alan J ^b   Miller, David H ^b   Chard, Declan T ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Longitudinal; MRI; Multiple sclerosis; Relapsing remitting; T I relaxation times

Indexed keywords

ADULT; ARTICLE; BRAIN DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FOLLOW UP; GRAY MATTER; HUMAN; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RECURRENT DISEASE; WHITE MATTER; BRAIN; CASE CONTROL STUDY; DISABILITY; DISEASE COURSE; FEMALE; MIDDLE AGED; PREDICTION AND FORECASTING; STATISTICAL MODEL; TIME;

ADULT; BRAIN; CASE-CONTROL STUDIES; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PREDICTIVE VALUE OF TESTS; TIME FACTORS;

EID: 77954662766     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509359924     Document Type: Article

References (33)

1. Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 2002;15:239-245.
2. Fisniku LK, Brex PA, Altmann DR, et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 2008;131:808-817.
3. Tintore M, Rovira A, Rio J, et al. Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology 2006;67:968-972.
4. Beck RW, Smith CH, Gal RL, et al. Neurologic impairment 10 years after optic neuritis. Arch Neurol 2004;61:1386-1389.
5. Minneboo A, Barkhof F, Polman CH, Uitdehaag BM, Knol DL, Castelijns JA. Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. Arch Neurol 2004;61:217-221.
6. Filippi M, Rocca MA. MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system. J Neurol 2005;252(suppl 5):v16-24. Review.
7. Ceccarelli A, Rocca MA, Falini A, et al. Normal-appearing white and grey matter damage in MS. A volumetric and diffusion tensor MRI study at 3.0 Tesla. J Neurol 2007;254:513-518.
8. Vrenken H, Geurts JJ, Knol DL, et al. Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter. Radiology 2006;240:811-820. (Pubitemid 44267339)
9. Vrenken H, Rombouts SA, Pouwels PJ, Barkhof F. Voxel-based analysis of quantitative T1 maps demonstrates that multiple sclerosis acts throughout the normal-appearing white matter. AJNR Am J Neuroradiol 2006;27:868-874.
10. Davies GR, Ramio-Torrenta L, Hadjiprocopis A, et al. Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2004;75:998-1002.
11. Parry A, Clare S, Jenkinson M, Smith S, Palace J, Matthews PM. MRI brain T1 relaxation time changes in MS patients increase over time in both the white matter and the cortex. J Neuroimaging 2003;13:234-239.
12. Cercignani M, Bozzali M, Iannucci G, Comi G, Filippi M. Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;70:311-317. (Pubitemid 32250886)
13. Rovaris M, Judica E, Ceccarelli A, et al. A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS. J Neurol 2008;255:1209-1214.
14. Davies GR, Hadjiprocopis A, Altmann DR, et al. Normal-appearing grey and white matter T1 abnormality in early relapsing-remitting multiple sclerosis: a longitudinal study. Mult Scler 2007;13:169-177.
15. Agosta F, Rovaris M, Pagani E, Sormani MP, Comi G, Filippi M. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain 2006;129:2620-2627.
16. Davies GR, Altmann DR, Hadjiprocopis A, et al. Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis. J Neurol 2005;252:1037-1044.
17. Griffin CM, Dehmeshki J, Chard DT, et al. T1 histograms of normal-appearing brain tissue are abnormal in early relapsing-remitting multiple sclerosis. Mult Scler 2002;8:211-216.
18. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907-911.
19. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
20. Lechner-Scott J, Kappos L, Hofman M, et al. Can the Expanded Disability Status Scale be assessed by telephone? Mult Scler 2003;9:154-159.
21. Parker GJ, Barker GJ, Tofts PS. Accurate multislice gradient echo T (1) measurement in the presence of non-ideal RF pulse shape and RF field nonuniformity. Magn Reson Med 2001;45:838-845.
22. Woods RP, Grafton ST, Holmes CJ, Cherry SR, Mazziotta JC. Automated Image Registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr 1998;22:139-152.
23. Grimaud J, Lai M, Thorpe J, et al. Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. Magn Reson Imaging 1996;14:499-505.
24. Ashburner J, Friston KJ. Voxel-based morphometry - the methods. Neuroimage 2000;11:805-821.
25. Kutzelnigg A, Faber-Rod JC, Bauer J, et al. Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol 2007;17:38-44.
26. Barnes D, McDonald WI, Johnson G, Tofts PS, Landon DN. Quantitative nuclear magnetic resonance imaging: characterisation of experimental cerebral oedema. J Neurol Neurosurg Psychiatry 1987;50:125-133.
27. Naruse S, Horikawa Y, Tanaka C, Hirakawa K, Nishikawa H, Yoshizaki K. Proton nuclear magnetic resonance studies on brain edema. J Neurosurg 1982;56:747-752.
28. Schmierer K, Scaravilli F, Altmann DR, Barker GJ, Miller DH. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 2004;56:407-415.
29. Schmierer K, Tozer DJ, Scaravilli F, et al. Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain. J Magn Reson Imaging 2007;26:41-51. (Pubitemid 47235229)
30. Geurts JJ, Pouwels PJ, Uitdehaag BM, Polman CH, Barkhof F, Castelijns JA. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 2005;236:254-260.
31. Manfredonia F, Ciccarelli O, Khaleeli Z, et al. Normal-appearing brain T1 relaxation time predicts disability in early primary progressive multiple sclerosis. Arch Neurol 2007;64:411-415. (Pubitemid 46425697)
32. Chapman C, Tubridy N, Cook MJ, et al. Short-term effects of methylprednisolone on cerebral volume in multiple sclerosis relapses. J Clin Neurosci 2006;13:636-638.
33. Saito N, Sakai O, Ozonoff A, Jara H. Relaxo-volumetric multispectral quantitative magnetic resonance imaging of the brain over the human lifespan: global and regional aging patterns. Magn Reson Imaging 2009;27:895-906.